NYSEMKT: MTNBMatinas Biopharma Holdings Inc Stock Ownership - Who owns Matinas Biopharma Holdings?
Insider buying vs selling
Have Matinas Biopharma Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when MTNB insiders and whales buy or sell their stock.
MTNB Shareholders
What type of owners hold Matinas Biopharma Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Adam K. Stern | 179.09% | 9,110,069 | $12.57M | Insider |
| Herbert J. Conrad | 169.15% | 8,604,510 | $11.87M | Insider |
| Roelof Rongen | 69.58% | 3,539,416 | $4.88M | Insider |
| Jennifer Lorenzo | 41.02% | 2,086,576 | $2.88M | Insider |
| Raphael J. Mannino | 37.74% | 1,919,715 | $2.65M | Insider |
| Abdel A. Fawzy | 33.82% | 1,720,186 | $2.37M | Insider |
| Jerome D. Jabbour | 16.51% | 840,011 | $1.16M | Insider |
| James S. Scibetta | 12.78% | 649,958 | $896.94k | Insider |
| Stefano Ferrari | 10.92% | 555,547 | $766.65k | Insider |
| Patrick G. Lepore | 7.86% | 400,000 | $552.00k | Insider |
MTNB vs Biotech Stocks
Matinas Biopharma Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.